A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.
Some experts said the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to penalties, legal action or prison.
Service Response and Content Elimination
According to TikTok, the platform has removed violative material and prohibited associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to nine thousand participants marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, filled with images of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.
After moments of joining one community, a seller posted WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Details and Pricing
Within these communities, posts display dark colored parcels with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service stated it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered individuals harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly significant medical dangers”.
